5 August 2021 - Australians suffering from a rare type of blood cancer will now have access to a highly specialised ...
5 August 2021 - Eligible patients can now access Yescarta through Peter MacCallum Cancer Centre, Melbourne and Royal Brisbane and Women’s ...
21 July 2021 - Skysona is the first and only gene therapy approved in the European Union to treat early CALD. ...
12 July 2021 - Korean leukaemia patients have urged the government to provide rapid reimbursement of Kymriah, the first CAR-T ...
9 July 2021 - OTL-200 (Libmeldy) is a gene therapy medicinal product that expresses the human ARSA gene. ...
30 June 2021 - TurboCAR technology provides selective, programmable cytokine signaling designed to improve function and potency of AlloCAR T cells. ...
25 June 2021 - Recommendation for approval based on results from pivotal KarMMa study. ...
24 June 2021 - The first CAR-T cell therapy approved by NMPA: opening a new era of cell therapy in China. ...
15 June 2021 - Today, the U.S. FDA approved StrataGraft for the treatment of adult patients with thermal burns containing intact ...
31 May 2021 - Abecma is the first personalised cell therapy available to Canadian patients for the treatment of adults ...
27 May 2021 - Upfront costs high but treatments may cut long-term expense and boost patient results. ...
26 May 2021 - Legend Biotech has announced that the U.S. FDA has accepted for priority review the biologics license application ...
14 May 2021 - The MSAC Secretariat has published a list of the applications scheduled to be considered at the ...
11 May 2021 - Independent appraisal committee unanimously determined the evidence is adequate to demonstrate that CAR-T treatments ide-cel and cilta-cel ...
30 April 2021 - Submission follows accelerated assessment granted by the Committee for Medicinal Products for Human Use of the European ...